Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03798626
Title Gevokizumab With Standard of Care Anti-cancer Therapies for Metastatic Colorectal, Gastroesophageal, and Renal Cancers
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | GBR | ESP | DEU | CAN | BEL | AUS

Facility Status City State Zip Country Details
University Of California Los Angeles UCLA Oncology Clinic Los Angeles California 90095 United States Details
Washington Uni School of Med Siteman Cancer Center Saint Louis Missouri 63110 United States Details
Sarah Cannon Research Institute Drug Ship - 4 Nashville Tennessee 37203 United States Details
Novartis Investigative Site Melbourne Victoria 3000 Australia Details
Novartis Investigative Site Edegem Antwerpen 2650 Belgium Details
Novartis Investigative Site Bruxelles 1000 Belgium Details
Novartis Investigative Site Leuven 3000 Belgium Details
Novartis Investigative Site Calgary Alberta T2N 4N2 Canada Details
Novartis Investigative Site Toronto Ontario M5G 1Z6 Canada Details
Novartis Investigative Site Santiago 8330074 Chile Details
Novartis Investigative Site Brno Czech Republic 656 53 Czechia Details
Novartis Investigative Site Dresden 01307 Germany Details
Novartis Investigative Site Frankfurt 60488 Germany Details
Novartis Investigative Site Ulm 89081 Germany Details
Novartis Investigative Site Ramat Gan 52621 Israel Details
Novartis Investigative Site Tel Aviv 6423906 Israel Details
Novartis Investigative Site Milano MI 20162 Italy Details
Novartis Investigative Site Rozzano MI 20089 Italy Details
Novartis Investigative Site Nagoya Aichi 464 8681 Japan Details
Novartis Investigative Site Kashiwa Chiba 277 8577 Japan Details
Novartis Investigative Site Osaka-city Osaka 541-8567 Japan Details
Novartis Investigative Site Sunto Gun Shizuoka 411 8777 Japan Details
Novartis Investigative Site Bunkyo-ku Tokyo 113-8603 Japan Details
Novartis Investigative Site Seoul 05505 Korea, Republic of Details
Novartis Investigative Site Singapore 119074 Singapore Details
Novartis Investigative Site Sevilla Andalucia 41013 Spain Details
Novartis Investigative Site Hospitalet de LLobregat Catalunya 08907 Spain Details
Novartis Investigative Site Valencia Comunidad Valenciana 46010 Spain Details
Novartis Investigative Site Madrid 28009 Spain Details
Novartis Investigative Site Madrid 28034 Spain Details
Novartis Investigative Site Madrid 28050 Spain Details
Novartis Investigative Site Tainan 70403 Taiwan Details
Novartis Investigative Site London SW3 6JJ United Kingdom Details
Novartis Investigative Site Manchester M20 4BX United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field